Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (9)

2023

  1. Arrhythmic Effects Evaluated on Caenorhabditis elegans: The Case of Polypyrrole Nanoparticles

    ACS Nano, Vol. 17, Núm. 17, pp. 17273-17284

2022

  1. Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome

    eLife, Vol. 11

  2. Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology

    npj Parkinson's Disease, Vol. 8, Núm. 1

2020

  1. The Emerging Role of the Lysosome in Parkinson's Disease

    Cells, Vol. 9, Núm. 11

2019

  1. Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome

    Neurobiology of Disease, Vol. 125, pp. 92-106

2015

  1. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

    JAMA - Journal of the American Medical Association, Vol. 313, Núm. 13, pp. 1347-1361

  2. Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair

    Gastroenterology, Vol. 149, Núm. 3, pp. 563-566

2014

  1. About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants

    International Journal of Cancer, Vol. 134, Núm. 9, pp. 2088-2097

2013

  1. Evaluation of Rare Variants in the New Fanconi Anemia Gene ERCC4 (FANCQ) as Familial Breast/Ovarian Cancer Susceptibility Alleles

    Human Mutation, Vol. 34, Núm. 12, pp. 1615-1618